欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NO/H/0219/002
药品名称Ceftriaxon IPP 2 g
活性成分
    • ceftriaxone sodium salt 2.0 g
剂型Powder for solution for infusion/injection
上市许可持有人MIP Pharma GmbH Kirkeler str. 41 66440 Blieskastel Germany
参考成员国 - 产品名称Norway (NO)
Ceftriaxon IPP
互认成员国 - 产品名称
    • Germany (DE)
      Ceftriaxon IPP 2 g Pulver zur Herstellung einer Injektions- bzw. Infusionslösung
    • Denmark (DK)
    • United Kingdom (Northern Ireland) (XI)
    • Sweden (SE)
    • Finland (FI)
    • Latvia (LV)
      Ceftriaxon IPP 2 g pulveris infūziju šķīduma pagatavošanai
    • Lithuania (LT)
      Ceftriaxone IPP 2 g milteliai infuziniam tirpalui
    • Estonia (EE)
      CEFTRIAXONE MIP 2 G
    • Hungary (HU)
      CEFTRIAXON MIP 2 g por oldatos infúzióhoz
许可日期2012/11/18
最近更新日期2024/05/21
药物ATC编码
    • J01DD04 ceftriaxone
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase